UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study

European journal of cancer (1990), 2015-03, Vol.51 (5), p.653-667

2015

Volltextzugriff (PDF)

Früherkennung und Prävention des malignen Melanoms

Der Onkologe, 2009-08, Vol.15 (8), p.738-743

2009

Volltextzugriff (PDF)

Systemische Therapie des metastasierten Melanoms

Der Onkologe, 2010-12, Vol.16 (12), p.1160-1166

2010

Volltextzugriff (PDF)

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.443-451

2018

Volltextzugriff (PDF)

1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors

Annals of oncology, 2024-09, Vol.35, p.S709-S709

2024

Volltextzugriff (PDF)

277 Site-Specific Tumor Response and Impact on Therapy Outcomes in Advanced Melanoma Patients

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S196-S196

2021

Volltextzugriff (PDF)

Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients

Annals of oncology, 2017-12, Vol.28 (12), p.3104-3106

2017

Volltextzugriff (PDF)

Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.2021-2025

2020

Volltextzugriff (PDF)

Kutanes Melanom

Der Onkologe, 2007-08, Vol.13 (8), p.745-758

2007

Volltextzugriff (PDF)

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial

European journal of cancer (1990), 2023-09, Vol.190, p.112941-112941, Article 112941

2023

Volltextzugriff (PDF)

LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial

Annals of oncology, 2024-09, Vol.35, p.S1235-S1236

2024

Volltextzugriff (PDF)

1093P Preliminary biomarker analysis in the phase III PIVOTAL study: Evidence for the mechanism of action of daromun in melanoma

Annals of oncology, 2024-09, Vol.35, p.S724-S725

2024

Volltextzugriff (PDF)

Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry

Journal of the European Academy of Dermatology and Venereology, 2019-01, Vol.33 (1), p.63-70

2019

Volltextzugriff (PDF)

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Annals of oncology, 2008-06, Vol.19 (6), p.1195-1201

2008

Volltextzugriff (PDF)

Late recurrence of melanoma after 10 years – Is the course of the disease different from early recurrences?

Journal of the European Academy of Dermatology and Venereology, 2020-05, Vol.34 (5), p.977-983

2020

Volltextzugriff (PDF)

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial

Annals of oncology, 2016-08, Vol.27 (8), p.1625-1632

2016

Volltextzugriff (PDF)

Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial

British journal of dermatology (1951), 2015-04, Vol.172 (4), p.926-932

2015

Volltextzugriff (PDF)

Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group

Journal of the European Academy of Dermatology and Venereology, 2012-01, Vol.26 (1), p.48-53

2012

Volltextzugriff (PDF)

Clinical course and prognostic factors of Merkel cell carcinoma of the skin

British journal of dermatology (1951), 2009-07, Vol.161 (1), p.90-94

2009

Volltextzugriff (PDF)

Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study

British journal of dermatology (1951), 2015-06, Vol.172 (6), p.1646-1650

2015

Volltextzugriff (PDF)

Pathogenesis of diabetic macro- and microangiopathy

Clinical nephrology, 2008-07, Vol.70 (1), p.1-9

2008

Volltextzugriff (PDF)

Vitamin D3 relevant für die Immunregulation?

Nieren- und Hockdruckkrankheiten, 2011-11, Vol.40 (11), p.463-472

2011

Volltextzugriff (PDF)

Atherosklerose – Pathogenese und Protektion. Die protektive Relevanz von Vitamin D3

Nieren- und Hockdruckkrankheiten, 2010-07, Vol.39 (7), p.263-270

2010

Volltextzugriff (PDF)

Morphologie und Pathogenese der Arteriosklerose: Sind Makro- und Mikroangiopathie beim Diabetes mellitus besondere Varianten?

Nieren- und Hockdruckkrankheiten, 2008-05, Vol.37 (5), p.197-207

2008

Volltextzugriff (PDF)

FC12 Long term follow-up of 72 melanoma patients after intratumoral treatment with interleukin-2: favorable survival and high rate of objective responses upon subsequent chemotherapy

Melanoma research, 2010-06, Vol.20, p.e34

2010

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(26)

Sprache

Englisch
(23)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study

Früherkennung und Prävention des malignen Melanoms

Systemische Therapie des metastasierten Melanoms

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors

277 Site-Specific Tumor Response and Impact on Therapy Outcomes in Advanced Melanoma Patients

Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients

Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry

Kutanes Melanom

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial

LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial

1093P Preliminary biomarker analysis in the phase III PIVOTAL study: Evidence for the mechanism of action of daromun in melanoma

Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Late recurrence of melanoma after 10 years – Is the course of the disease different from early recurrences?

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial

Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial

Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group

Clinical course and prognostic factors of Merkel cell carcinoma of the skin

Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study

Pathogenesis of diabetic macro- and microangiopathy

Vitamin D3 relevant für die Immunregulation?

Atherosklerose – Pathogenese und Protektion. Die protektive Relevanz von Vitamin D3

Morphologie und Pathogenese der Arteriosklerose: Sind Makro- und Mikroangiopathie beim Diabetes mellitus besondere Varianten?

FC12 Long term follow-up of 72 melanoma patients after intratumoral treatment with interleukin-2: favorable survival and high rate of objective responses upon subsequent chemotherapy

Suchergebnisse filtern